Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Elf nieuwe risico-loci gevonden voor hersenaneurysmata
jan 2021 | Neuro-vasculair